• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The PROGRESS trial three years later: time for more action, less distraction.

作者信息

Macmahon Stephen, Neal Bruce, Rodgers Anthony, Chalmers John

机构信息

The George Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia.

出版信息

BMJ. 2004 Oct 23;329(7472):970-1. doi: 10.1136/bmj.329.7472.970.

DOI:10.1136/bmj.329.7472.970
PMID:15499117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC524115/
Abstract
摘要

相似文献

1
The PROGRESS trial three years later: time for more action, less distraction.三年后的PROGRESS试验：是时候采取更多行动、减少干扰了。
BMJ. 2004 Oct 23;329(7472):970-1. doi: 10.1136/bmj.329.7472.970.
2
The PROGRESS trial three years later: time for a balanced report of effectiveness.三年后的PROGRESS试验：是时候进行一份关于疗效的平衡报告了。
BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968.
3
[Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].[脑血管疾病：INDANA荟萃分析和PROGRESS试验的影响]
Nihon Rinsho. 2004 Mar;62 Suppl 3:605-11.
4
[PROGRESS].[进展]
Nihon Rinsho. 2006 Aug;64 Suppl 6:396-401.
5
Combination BP therapy cuts second stroke risk in half.
Geriatrics. 2001 Aug;56(8):14, 16.
6
You should treat patients over the age of 80 who have hypertension.你应该治疗80岁以上患有高血压的患者。
Medscape J Med. 2008;10(8):185. Epub 2008 Aug 7.
7
[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Presse Med. 2001 Nov 24;30(35):1716-7.
8
The PROGRESS trial three years later: HOPE trial may shed some light.三年后的PROGRESS试验：HOPE试验可能会提供一些线索。
BMJ. 2004 Dec 11;329(7479):1403-4. doi: 10.1136/bmj.329.7479.1403-d.
9
Secondary prevention for stroke and transient ischaemic attacks.中风和短暂性脑缺血发作的二级预防。
BMJ. 2004 Feb 7;328(7435):297-8. doi: 10.1136/bmj.328.7435.297.
10
Blood pressure and stroke; the PROGRESS trial.血压与中风；PROGRESS试验。
J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):153-5. doi: 10.3317/jraas.2001.021.

引用本文的文献

1
Understanding and managing hypertension in an African sub-district: a multidisciplinary approach.非洲一个分区的高血压理解与管理：多学科方法
Scand J Public Health Suppl. 2007 Aug;69:52-9. doi: 10.1080/14034950701355411.
2
Delapril plus indapamide: a review of the combination in the treatment of hypertension.地拉普利加吲达帕胺：联合用药治疗高血压的综述
Clin Drug Investig. 2007;27(6):367-80. doi: 10.2165/00044011-200727060-00001.
3
ASCOT: a tale of two treatment regimens: odds are that it's hype.ASCOT：两种治疗方案的故事：很可能只是炒作。
BMJ. 2005 Oct 29;331(7523):1022-3. doi: 10.1136/bmj.331.7523.1022-b.
4
Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy.中风相关基因鉴定的进展：为中风治疗理念的发展带来新的可能性。
CNS Drugs. 2005;19(10):821-32. doi: 10.2165/00023210-200519100-00002.
5
Perindopril monotherapy and PROGRESS in Europe.培哚普利单药治疗与欧洲的PROGRESS研究
BMJ. 2005 Jul 23;331(7510):235-6. doi: 10.1136/bmj.331.7510.235-b.

本文引用的文献

1
The PROGRESS trial three years later: time for a balanced report of effectiveness.三年后的PROGRESS试验：是时候进行一份关于疗效的平衡报告了。
BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968.
2
Secondary prevention for stroke and transient ischaemic attacks.中风和短暂性脑缺血发作的二级预防。
BMJ. 2004 Feb 7;328(7435):297-8. doi: 10.1136/bmj.328.7435.297.
3
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.不同降压方案对主要心血管事件的影响：前瞻性设计的随机试验综述结果
Lancet. 2003 Nov 8;362(9395):1527-35. doi: 10.1016/s0140-6736(03)14739-3.
4
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.基于培哚普利的降压方案对6105例脑血管疾病患者残疾和依赖状况的影响：一项随机对照试验
Stroke. 2003 Oct;34(10):2333-8. doi: 10.1161/01.STR.0000091397.81767.40. Epub 2003 Sep 4.
5
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.2003年欧洲高血压学会-欧洲心脏病学会动脉高血压管理指南
J Hypertens. 2003 Jun;21(6):1011-53. doi: 10.1097/00004872-200306000-00001.
6
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告：JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
7
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.基于培哚普利的降压方案对脑血管疾病患者心脏结局的影响。
Eur Heart J. 2003 Mar;24(5):475-84. doi: 10.1016/s0195-668x(02)00804-7.
8
The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
Am J Hypertens. 2002 May;15(5):472-4. doi: 10.1016/s0895-7061(02)02928-x.
9
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.在6105名曾患中风或短暂性脑缺血发作的个体中，基于培哚普利的降压方案的随机试验。
Lancet. 2001 Sep 29;358(9287):1033-41. doi: 10.1016/S0140-6736(01)06178-5.
10
Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group.脑血管疾病患者的血压与中风风险。英国短暂性脑缺血发作协作组。
BMJ. 1996 Jul 20;313(7050):147. doi: 10.1136/bmj.313.7050.147.